News
Ellipsoid zone (EZ) loss has been proposed as evidence of progression of several retinal degenerative diseases, including, but not limited to, retinitis pigmentosa and hydroxychloroquine (HCQ)-induced retinal toxicity. HCQ is a first-line drug used to treat autoimmune diseases such as systemic lupus
IRP Senior Investigator and Inventor Dr. Peter Choyke has been elected to the National Academy of Medicine (NAM). Dr. Choyke is the Director of the National Cancer Institute’s Molecular Imaging Branch. He was elected for his work on improving diagnosis and treatment through imaging technologies for
The National Center for Advancing Translational Sciences (NCATS) Office of Strategic Alliances is hosting a f ederal technology transfer workshop focused on measuring impact, innovation, and efficiencies. This event is intended for technology transfer professionals, policy makers, and innovators to
Curious what the NIH Tech Transfer Community accomplished in Fiscal Year (FY) 2020? Read the Annual Report and find out! This report details updates from the Institutes and Centers, an overview of FY2020’s inventions and agreements, and an introduction from OTT’s new director. The report tells